| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0003 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |